ISSN 2415-3060 (print), ISSN 2522-4972 (online)
  • 29 of 44
Up
УЖМБС 2022, 7(3): 200–205
https://doi.org/10.26693/jmbs07.03.200
Clinical Medicine

Anemia as a Cardiovascular Risk Factor in Patients with Chronic Heart Failure

Tsyganenko I. V., Ovcharenko L. K., Zaіats Yu. B.
Abstract

The purpose of the study was to investigate the clinical and prognostic significance of anemia, including iron deficiency, in patients with chronic heart failure. Materials and methods. A retrospective cohort study was conducted among 46 patients of the Poltava Regional Cardiovascular Center of the Poltava Regional Council, who in 2021 were on out-patient and in-patient treatment diagnosed with chronic heart failure of various functional classes. The information was collected by analyzing the data of laboratory examinations of patients during life, which were recorded in their medical records. Results and discussion. Cardiovascular disease is identified as the leading cause of death in people regardless of age and sex worldwide. About half of all hospitalizations each year is the result of cardiovascular disease, including acute myocardial infarction, chronic heart failure, cardiomyopathy, and life-threatening cardiac arrhythmias. Increasing attention is being paid to finding the causes of cardiovascular risk, which also significantly affect the degree of manifestations and progression of certain pathogenetic changes in the human body. Recently, anemia has been increasingly singled out as one of these factors. It is proved that iron deficiency significantly reduces the quality of life, physical activity both in the presence of anemia and in its absence. Recent recommendations from the European Society of Cardiology for Heart Failure recommend that all patients with heart failure be screened for serum ferritin and transferrin, with or without anemia and iron deficiency. However, the question remains – cardiovascular risk factor. It was found that the degree of progression of anemia is directly related to the degree of progression of chronic heart failure. In more than half of the patients, anemia was a predictor of cardiovascular disease. In patients with primary kidney disease, anemia develops in almost all cases and contributes to postoperative complications. The degree of pathogenetic, clinical, diagnostic and therapeutic relationship between these pathological conditions demonstrates that anemia is a marker of subclinical chronic renal failure in patients with heart failure. Thus, anemia is not only a direct factor in cardiovascular risk but also a cause of unfavorable prognosis. Conclusion. Anemia can be identified as one of the risk factors for cardiovascular disease and factors for its progression. There is a direct relationship between functional classification of heart failure and the severity of anemia. All patients with iron deficiency were diagnosed with III-IV functional classification of heart failure. Already at the detection of primary hematological changes that indicate the presence and development of anemia, a comprehensive examination of the patient should be conducted and an appropriate therapy, depending on the genesis of anemia, which will reduce cardiovascular risk in the future, should be initiated

Keywords: chronic heart failure, anemia, cardiovascular risk, functional class, hemoglobin

Full text: PDF (Ukr) 258K

References
  1. Savarese G, Lund LH. Global Public Health Burden of Heart Failure. Card Fail Rev. 2017 Apr;3(1):7-11. https://doi.org/10.15420/cfr.2016:25:2
  2. WRITING COMMITTEE MEMBERS, Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Drazner MH, et al. 2013 ACCF/AHA CHF Guideline for the Management of Heart Failure: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2013 Oct 15;128(16):e240-327. PMID: 23741058. https://doi.org/10.1161/CIR.0b013e31829e8776
  3. World Health Organization. Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. 2011. Available from: https://apps.who.int/iris/bitstream/handle/10665/85839/WHO_NMH_NHD_MNM_11.1_eng.pdf
  4. Kassebaum NJ, Jasrasaria R, Naghavi M, Wulf SK, Johns N, Lozano R, et al. A systematic analysis of global anemia burden from 1990 to 2010. Blood. 2014 Jan 30;123(5):615-24. PMID: 24297872. PMCID: PMC3907750. https://doi.org/10.1182/blood-2013-06-508325
  5. Correale M, Paolillo S, Mercurio V, Limongelli G, Barillà F, Ruocco G, et al. Comorbidities in chronic heart failure: an update from Italian Society of Cardiology (SIC) working group on heart failure. Eur J Intern Med. 2020 Jan;71:23-31. PMID: 31708358. https://doi.org/10.1016/j.ejim.2019.10.008
  6. Auerbach M, Adamson JW. How we diagnose and treat iron deficiency anemia. Am J Hematol. 2016 Jan;91(1):31-8. PMID: 26408108. https://doi.org/10.1002/ajh.24201
  7. Jankowska EA, von Haehling S, Anker SD, Macdougall IC, Ponikowski P. Iron deficiency and heart failure: diagnostic dilemmas and therapeutic perspectives. Eur Heart J. 2013 Mar;34(11):816-829. PMID: 23100285. PMCID: PMC3596759. https://doi.org/10.1093/eurheartj/ehs224
  8. Nemeth E, Tuttle MS, Powelson J, Vaughn MB, Donovan A, Ward DM, et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science. 2004 Dec;306(5704):2090-3. PMID: 15514116. https://doi.org/10.1126/science.1104742
  9. Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European society of cardiology (ESC). Developed with the special contribution of the heart failure association (HFA) of the ESC. Eur J Heart Fail. 2016;18:891-975. PMID: 27207191. https://doi.org/10.1002/ejhf.592
  10. Hollenberg SM, Warner Stevenson L, Ahmad T, Amin VJ, Bozkurt B, Butler J, et al. 2019 ACC expert consensus decision pathway on risk assessment, management, and clinical trajectory of patients hospitalized with heart failure: a report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol. 2019;74:1966-2011. PMID: 31526538. https://doi.org/10.1016/j.jacc.2019.08.001
  11. Seferovic PM, Ponikowski P, Anker SD, Bauersachs J, Chioncel O, Cleland JGF. Clinical practice update on heart failure 2019: pharmacotherapy, procedures, devices and patient management. An expert consensus meeting report of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2019;21:1169-1186. PMID: 31129923. https://doi.org/10.1002/ejhf.1531
  12. Silverberg DS, Wexler D, Blum M, Iaina A. The cardio-renal-anemia sydrome. Correcting anemia in patients with resistant congestive heart failure can improve both cardiac and renal function and reduce hospitalizations. Clin Nephrol. 2003;60 Suppl 1S:93-102. PMID: 12940539
  13. Damman K, Valente MAE, Voors AA, O'Connor CM, van Veldhuisen DJ, Hillege HL. Renal impairement worsening renal function, and outcome in patients with heart failure: an updated meta-analysis. Eur Heart J. 2014 Feb;35(7):455-69. PMID: 24164864. https://doi.org/10.1093/eurheartj/eht386
  14. Ponikowski P, Kirwan BA, Anker SD, McDonagh T, Dorobantu M, Drozdz J, et al. AFFIRM-AHF investigators. Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial. Lancet. 2020 Dec 12;396(10266):1895-1904. PMID: 33197395. https://doi.org/10.1016/S0140-6736(20)32339-4
  15. Toblli JE, Lombrana A, Duarte P, Di Gennaro F. Intravenous iron reduces NT‐pro‐brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency. J Am Coll Cardiol. 2007;50:1657-1665. PMID: 17950147. https://doi.org/10.1016/j.jacc.2007.07.029
  16. Haehling S, Gremmler U, Krumm M, Mibach F, Schön N, Taggeselle J, et al. Prevalence and clinical impact of iron deficiency and anaemia among outpatients with chronic heart failure: the PrEP Registry. Clin Res Cardiol. 2017;106:106436-43. PMID: 28229219. PMCID: PMC5442200. https://doi.org/10.1007/s00392-016-1073-y
  17. Grote Beverborg N, van Veldhuisen DJ, van der Meer P. Anemia in Heart Failure: Still Relevant? JACC Heart Fail. 2018;6(3):201-208. PMID: 29128254. https://doi.org/10.1016/j.jchf.2017.08.023
  18. Caramelo C, Gil P. Insuficiencia combinada cardiorrenal: una clave evolutiva y terapéutica en el fallo cardíaco [Combined cardio-renal failure: a key factor in heart failure progression and therapy]. Rev Esp Cardiol. 2006 Feb;59(2):87-90. [Spanish]. PMID: 16540027. https://doi.org/10.1157/13084633
  19. Anand IS, Gupta P. Anemia and iron deficiency in heart failure. Circulation. 2018;138:80-98. PMID: 29967232. https://doi.org/10.1161/CIRCULATIONAHA.118.030099